Traphagen Investment Advisors LLC Amgen Inc Transaction History

Traphagen Investment Advisors LLC

  • $938 Billion
  • Q1 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 1,369 shares of AMGN stock, worth $423,541. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,369
Holding current value
$423,541
% of portfolio
0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$268.87 - $324.56 $368,083 - $444,322
1,369 New
1,369 $389 Million
Q4 2023

Jun 17, 2024
SELL
$255.7 - $288.46 $2,812 - $3,173
-11 Reduced 0.8%
1,358 $391 Million
Q3 2023

Jun 17, 2024
SELL
$218.65 - $271.46 $34,328 - $42,619
-157 Reduced 11.47%
1,212 $326 Million
Q2 2023

Jun 17, 2024
SELL
$214.27 - $253.37 $40,711 - $48,140
-190 Reduced 13.88%
1,179 $262 Million
Q1 2023

Jun 17, 2024
BUY
$225.79 - $275.2 $40,867 - $49,811
181 Added 17.0%
1,246 $301 Million
Q4 2022

Jun 17, 2024
SELL
$229.03 - $291.01 $69,625 - $88,467
-304 Reduced 22.21%
1,065 $280 Million
Q3 2022

Jun 17, 2024
SELL
$224.46 - $253.15 $183,159 - $206,570
-816 Reduced 0.94%
85,820 $11.9 Billion
Q2 2022

Jun 17, 2024
BUY
$230.71 - $256.74 $19.7 Million - $21.9 Million
85,267 Added 6228.41%
86,636 $11.8 Billion
Q1 2022

Jun 17, 2024
BUY
$219.27 - $242.57 $17.2 Million - $19.1 Million
78,648 Added 5834.42%
79,996 $14 Billion
Q4 2021

Jun 17, 2024
SELL
$198.88 - $227.6 $4,176 - $4,779
-21 Reduced 1.53%
1,348 $303 Million
Q3 2021

Jun 17, 2024
BUY
$212.27 - $248.7 $3,184 - $3,730
15 Added 1.14%
1,333 $283 Million
Q2 2021

Jun 17, 2024
SELL
$233.58 - $259.14 $22,423 - $24,877
-96 Reduced 6.79%
1,318 $321 Million
Q1 2021

Jun 17, 2024
BUY
$221.91 - $258.6 $9,985 - $11,637
45 Added 3.29%
1,414 $352 Million
Q4 2020

Jun 17, 2024
BUY
$216.38 - $257.67 $1,298 - $1,546
6 Added 0.45%
1,330 $306 Million
Q3 2020

Jun 17, 2024
BUY
$234.65 - $260.95 $75,557 - $84,025
322 Added 32.14%
1,324 $337 Million
Q2 2020

Jun 17, 2024
SELL
$197.81 - $242.74 $72,596 - $89,085
-367 Reduced 26.81%
1,002 $236 Million
Q1 2020

Jun 17, 2024
SELL
$182.24 - $241.7 $67,064 - $88,945
-368 Reduced 26.88%
1,001 $203 Million
Q4 2019

Jun 17, 2024
SELL
$189.21 - $243.2 $80,792 - $103,846
-427 Reduced 31.19%
942 $227 Million

Others Institutions Holding AMGN

# of Institutions
2,933
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email